| Drug Name |
Lanthanum carbonate |
| Drug ID |
BADD_D01247 |
| Description |
Lanthanum carbonate is a phosphate binder commonly used in clinical practice. It is marketed under the trade name _Fosrenol_ by Shire Pharmaceuticals. It is the largest of all pills filled in community pharmacies. Sometimes patients forget that Fosrenol is not swallowed whole, but instead should be chewed. This has led to severe choking. It is prescribed for treating high phosphate levels, mainly found in patients with chronic kidney disease. Lanthanum should be taken with meals and binds to phosphate in the diet, preventing phosphate absorption in the intestine. |
| Indications and Usage |
Used to reduce serum phosphate in patients with end stage renal disease (ESRD). |
| Marketing Status |
approved |
| ATC Code |
V03AE03 |
| DrugBank ID |
DB06792
|
| KEGG ID |
D04667
|
| MeSH ID |
C119467
|
| PubChem ID |
168924
|
| TTD Drug ID |
D0H1LO
|
| NDC Product Code |
0093-5939; 0093-5940; 71052-658; 66993-422; 68180-820; 65015-728; 66022-0116; 0093-5938; 54092-252; 54092-256; 66993-423; 69097-934; 76282-477; 68180-821; 54092-253; 68180-819; 66993-424; 76282-478; 69097-936; 76282-476; 49964-0035; 54092-254; 69097-935; 54092-257 |
| UNII |
490D9F069T
|
| Synonyms |
lanthanum carbonate | lantharenol | Fosrenol |
